1. Home
  2. MYSZ vs VBIO Comparison

MYSZ vs VBIO Comparison

Compare MYSZ & VBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo My Size Inc.

MYSZ

My Size Inc.

BUY

Current Price

$1.05

Market Cap

1.1M

Sector

Technology

ML Signal

BUY

Logo Valion Bio Inc. Common Stock

VBIO

Valion Bio Inc. Common Stock

HOLD

Current Price

$0.93

Market Cap

1.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYSZ
VBIO
Founded
1999
2016
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1M
1.1M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
MYSZ
VBIO
Price
$1.05
$0.93
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
65.8K
★ 658.1K
Earning Date
11-13-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 57.40
N/A
EPS
N/A
★ N/A
Revenue
$142,000.00
★ $780,000.00
Revenue This Year
$38.86
N/A
Revenue Next Year
$9.69
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 125.40
N/A
52 Week Low
$0.37
$0.12
52 Week High
$298.80
$812.50

Technical Indicators

Market Signals
Indicator
MYSZ
VBIO
Relative Strength Index (RSI) 23.25 22.28
Support Level $0.37 $0.12
Resistance Level $2.60 $4.39
Average True Range (ATR) 0.15 0.18
MACD 0.27 1.97
Stochastic Oscillator 6.45 0.75

Price Performance

Historical Comparison
MYSZ
VBIO

About MYSZ My Size Inc.

My Size Inc is a fashion technology company operating an integrated portfolio of businesses designed to address the pressing challenges facing fashion brands and retailers today - size and fit accuracy, excess inventory management, circular economy solutions, and international market distribution. The company, through its subsidaries provide end-to-end support across the fashion value chain; delivers AI-driven size and fit solutions for fashion e-commerce companies. The firm has the following four segments: (i) Fashion e-commerce platform, (ii) SaaS solutions, (iii) resale platform for apparel, and (iv) wholesaling of footwear. The company generates the majority of its revenue from the fashion e-commerce platform segment.

About VBIO Valion Bio Inc. Common Stock

Valion Bio Inc is a late-stage biopharmaceutical company developing biologics that activate innate immune pathways for cytoprotection and immune modulation. Its main candidate, Entolimod, is a TLR5 agonist and also advances Entolasta, a next-generation TLR5 agonist, and targets the neutropenia oncology supportive care market.

Share on Social Networks: